Bank Of America Corp Athersys, Inc Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $12,592 - $60,165	-69,960 Reduced 19.1%	296,364 $77,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $177,390 - $313,390	-295,651 Reduced 44.66%	366,324 $222,000
Q4 2021 Feb 08, 2022	BUY	$0.85 - $1.4 $288,201 - $474,683	339,060 Added 105.0%	661,975 $597,000
Q3 2021 Nov 15, 2021	BUY	$1.33 - $1.77 $37,611 - $50,053	28,279 Added 9.6%	322,915 $429,000
Q2 2021 Sep 13, 2021	BUY	$1.41 - $1.94 $415,436 - $571,593	294,636 New	294,636 $424,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.